News & Perspective

Jun 13, 2007

Jun 13, 2007

EU approves Novartis's cell-based flu vaccine

(CIDRAP News) – The European Union (EU) has approved Novartis's seasonal influenza vaccine, Optaflu, putting the Swiss company in a position to become the first to market a flu vaccine grown in cell culture rather than eggs.